Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Lotus Mallbris
Based on 56 articles published since 2008
||||
Expertise Level
The expertise of Lotus Mallbris ranks in the
  • Top 0.33%
  • ... of 37,573 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 56 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Mallbris, L   ·   Mallbris, Lotus
Work Locations
Details
Most likely:    Eli Lilly Corporation      
2018
  • Central Dermatology, St. Louis, Missouri. Electronic address: · Innovaderm Research Inc, Montreal, Quebec, Canada; Medical University of Graz, Graz, Austria. · Charité Universitätsmedizin Berlin, Berlin, Germany. · Eli Lilly and Company, Indianapolis, Indiana. · Buenos Aires Skin SA, Buenos Aires, Argentina. · Department of Dermatology, Westmead Hospital Dermatology Service, The University of Sydney, Westmead, Australia. · Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Pubmed 29803904
  • Herlev and Gentofte Hospital, Hellerup, Denmark. Electronic address: · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · University Hospitals Case Medical Center, Cleveland, Ohio. · Ameriderm Research, Ormond Beach, Florida; University of Central Florida, Orlando, Florida; University of Illinois, Urbana, Illinois. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 29548945
  • Dermatology Department, Toulouse University and Larrey Hospital, Toulouse, France. · Western University, London, ON, Canada. · Guenther Research Inc., London, ON, Canada. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Medicine (Dermatology), David Geffen School of Medicine, Los Angeles, CA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Division of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, USA. · Laval University and Centre de Recherche Dermatologique du Quebec Metropolitain, Quebec City, QC, Canada. · Pubmed 28881462
2017
  • Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Eli Lilly and Company, Indianapolis, IN, USA. · St. Louis University School of Medicine, St. Louis, MO, USA. · Pubmed 28370467
  • Oregon Medical Research Center, Suite G, 9495 S. Locust Street, Portland, OR 97223, OR, U.S.A. · Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K. · Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, NY, U.S.A. · Psoriasis Center at the Department of Dermatology, University Medical Centre Schleswig-Holstein, Campus Kiel, Germany. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. · Eli Lilly and Co., Indianapolis, IN, U.S.A. · Eli Lilly Belgium, Brussels, Belgium. · Dermatologikum Hamburg, Hamburg, Germany. · Pubmed 28301048
  • Oregon Medical Research Center, Portland, OR, USA. · Probity Medical Research and K. Papp Clinical Research, Waterloo, ON, Canada. · Department of Medicine (Dermatology), David Geffen School of Medicine, Los Angeles, CA, USA. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg, Hamburg, Germany. · Department of Dermatology, Miller School of Medicine, University of Miami, Miami, FL, USA. · Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan. · Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Department of Dermatology, Jichi Medical University, Shimotsuke, Tochigi, Japan. · Department of Medicine, Université Laval, Hôpital Hôtel-Dieu de Québec, Quebec, QC, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Quebec, QC, Canada. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 28190255
  • Oregon Medical Research Center, 9495 SW Locust St., Suite G, Portland, OR, 97223, USA. · K Papp Clinical Research and Probity Medical Research, Waterloo, Canada. · Dermatology Centre, Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical Dermatology Specialists, Inc., Atlanta, GA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28074446
  • Department of Dermatology, University of Utah, Salt Lake City, UT, USA. · Psoriasis Treatment Center of Central New Jersey, Windsor, NJ, USA. · Altman Dermatology Associates, Arlington Heights, IL, USA. · Lilly-NUS Centre for Clinical Pharmacology, Singapore City, Singapore. · Eli Lilly and Company, Indianapolis, IN, USA. · Eli Lilly and Company, Windlesham, UK. · Pubmed 27500949
  • Dermatologikum Hamburg and Georg-August-University, Göttingen, Germany. Electronic address: · Central Dermatology, St Louis, Missouri, USA. · K. Papp Clinical Research, Probity Medical Research, Waterloo, Ontario, Canada. · Department of Dermatology, New York Medical College, Valhalla, New York, USA. · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28780085
  • K. Papp Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Service de Dermatologie, AP-HP Hôpital Saint Louis, Sorbonne Paris Cité Université Paris Diderot, Paris, France. · Oregon Medical Research Center, Portland, OR, U.S.A. · Oregon Health and Science University, Portland, OR, U.S.A. · Departament of Dermatology, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil. · Department of Dermatology, Jichi Medical University, Shimotsuke, Japan. · Eli Lilly and Company, Indianapolis, IN, U.S.A. · Department of Dermatology, University of Connecticut Health Center, Farmington, CT, U.S.A. · Pubmed 28600810
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · The Danish Heart Foundation, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermatology, New York Medical College, Valhalla, New York, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK. · Department of Dermatology, Edouard Herriot Hospital, University Claude Bernard Lyon-1, University of Lyon, Lyon, France. · Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy. · Division of Rheumatology, Department of Medicine, University of Toronto, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28483767
  • Department of Dermatology, University of Connecticut Health Center and Probity Medical Research, Farmington, Connecticut. Electronic address: · Central Dermatology PC, St Louis, Missouri. · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Psoriasis-Center, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Jichi Medical University, Shimotsuke, Tochigi, Japan. · Innovaderm Research, Montreal, Canada. · Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Dermatology, Paul Sabatier University, Toulouse, France. · Icahn School of Medicine at Mount Sinai, New York, New York. · Eli Lilly and Company, Indianapolis, Indiana. · Dermatologikum Hamburg and SCIderm, Hamburg, Germany. · Pubmed 27889292
  • Department of Dermatology, New York Medical College, Valhalla, NY, USA. · Department of Dermatology, University Hospital of Nice, Nice, France. · Murdough Family Center for Psoriasis, University Hospitals Case Medical Center, Cleveland, OH, USA. · Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg, Germany. · Regional Medical Affairs, Lilly France, Neuilly-sur-Seine, France. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Dermatology, Psoriasis-Center, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 27696577
2016
  • From the Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago (K.B.G.) · Oregon Medical Research Center, Portland (A.B.) · K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), and the Department of Medicine, Division of Dermatology, Dalhousie University, Halifax, NS (R.G.L.) - both in Canada · the Department of Dermatology, University of Münster, Münster (T.L.), and SCIderm Research Institute and Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany · the Department of Dermatology, Jichi Medical University, Shimotsuke-shi, Japan (M.O.) · Lilly Research Laboratories, Eli Lilly, Indianapolis (D.A., S.G.B., D.K.B., G.S.C., J.E., R.J.K., T.M.M., B.J.N., O.O.O., R.J.S., F.Z., L.M.) · and the Department of Dermatology, Saint Louis University School of Medicine, St. Louis (C.L.L.). · Pubmed 27299809
Probable:    Karolinska Institutions      
2017
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. · Unit of Dermatology and Venerology, Karolinska Institutet, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Department of Dermatology, Department of Biostatistics and Epidemiology, and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania. · National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: · Pubmed 28826925
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Departments of Dermatology, Preventive Medicine, and Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Northwestern Medicine Multidisciplinary Eczema Center, Chicago, Illinois. · Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Pubmed 27742169
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Stockholm, Sweden. · The Danish Heart Foundation, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Psoriasis-Center at the Dept. of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Pubmed 27439545
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · Dermatology Centre, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · The Danish Heart Foundation, DK-1127, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, DK-1353, Copenhagen, Denmark. · Pubmed 28555725
2016
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; The Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Pubmed 27283226
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · The Danish Heart Foundation, DK-1127, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, DK-1353, Copenhagen, Denmark. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 27038335
  • Department of Dermato-Allergology, University of Copenhagen, 2900, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, M6 8HD, U.K. · Sorbonne Paris Cité Université Paris Diderot, INSERM U1163, Imagine Institute, Necker Hospital, Paris, France. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · The Danish Heart Foundation, DK-1127, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, DK-1353, Copenhagen, Denmark. · Department of Dermato-Allergology, University of Copenhagen, 2900, Hellerup, Denmark. · Pubmed 26959083
  • Probity Medical Research and K. Papp Clinical Research Inc, Waterloo, Ontario, Canada. · Rockefeller University, New York, New York. · Wake Forest Baptist Health, Winston-Salem, North Carolina. · Dalhousie University, Halifax, Nova Scotia, Canada. · Comprehensive Center for Inflammation Research, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Dermatology, University of Texas Medical School, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 26899199
  • Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; The Danish Heart Foundation, Copenhagen, Denmark; The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Pubmed 26763428
  • Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900 Hellerup. · Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900 Hellerup. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 26715401
2015
  • Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Pubmed 26386630
  • Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark2The Danish Heart Foundation, Copenhagen, Denmark3National Institute of Public Health, University of Southern Denmark, Copenhagen. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Pubmed 26222707
  • Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, DK-2900, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermato-allergology, Gentofte Hospital, University of Copenhagen, Hellerup, DK-2900, Denmark. · Pubmed 25801416
  • Department of Cardiology, Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermato-allergology, Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Pubmed 25781210
2010
  • Unit of Dermatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19645825
2009
  • Dermatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19480679
2016
  • Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Pubmed 26716136
2015
  • Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Pubmed 25766866
2009
  • Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19734975
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19133922
2008
  • Department of Medicine, Molecular Unit of Dermatology and Venereology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden. · Pubmed 18200047
Probable:    Pfizer      
2017
  • The Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. · Dermatrials Research Inc, Hamilton, ON, Canada. · UCLA School of Medicine, Los Angeles, CA, USA. · Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Indiana School of Medicine, Indianapolis, IN, USA. · DermResearch PLLC, Louisville, KY, USA. · Pfizer Inc, Global Innovative Pharmaceuticals, Groton, CT, USA. · Pfizer Inc, Collegeville, PA, USA. · Pubmed 27600367
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Quality Measures and Research, Clalit Health Services, Tel Aviv, Israel; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. · University of Texas Health Science Center, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Collegeville, Pennsylvania. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark. · Pfizer Inc, New York, New York. · Pubmed 28711084
  • Division of Rheumatology, Department of Musculoskeletal Sciences, University Hospitals Leuven, Belgium. · Pfizer, Collegeville, PA, USA. · inVentiv Health, Princeton, NJ, USA. · Pubmed 27606545
2016
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Skin Center for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Clinica Dermacross, Santiago, Chile. · Pfizer Inc, Collegeville, Pennsylvania. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, New York, New York. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 27692733
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Toulouse University and Larrey Hospital, Toulouse, France. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Pubmed 27271195
2015
  • Dermatology Centre, Manchester Academic Health Science Centre, Salford Royal Hospital, University of Manchester, M6 8HD, Manchester, U.K. · University of Kiel, Kiel, Germany. · Specialty Care, Pfizer Inc, Collegeville, PA, U.S.A. · Pubmed 25913550
  • Innovaderm Research, Montreal, QC, Canada. · Aarhus University Hospital, Aarhus, Denmark. · Department of Medicine/Dermatology, UCLA School of Medicine, Los Angeles, CA, U.S.A. · Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, U.K. · Skin and Cancer Foundation Inc., The University of Melbourne, Carlton, Vic., Australia. · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Pfizer Inc, Groton, CT, U.S.A. · Pfizer Inc, New York, NY, U.S.A. · Pfizer Inc, Collegeville, PA, U.S.A. · Pubmed 25418186
  • Guy's and St Thomas' NHS Foundation Trust, London, UK. · Katholieke Universiteit Leuven, Leuven, Belgium. · Quintiles, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Europe, Rome, Italy. · Pubmed 25535650
  • Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Hospital General de Agudos, Buenos Aires, Argentina. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Specialty Care, Medical Affairs Europe, Inflammation, Rome, Italy. · Pfizer Italia S.r.l., Rome, Italy. · Formerly of Pfizer Inc, Collegeville, PA, USA. · Pubmed 25376448
2014
  • Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain. · St Vincent's University Hospital, Elm Park, Dublin, Ireland. · Lotus Mallbris, Pfizer Global Medical Dermatology Lead, Philadelphia, USA. · Department of Dermatology, Federal Academic Teaching Hospital, Feldkirch, Austria. · Pubmed 24752135
2014
  • Formerly of Pfizer Inc,, 3921 Glenlake Garden Drive, Raleigh, NC 27612, USA. · Pubmed 25091090
2013
  • Department of Health Economics, Pfizer AB, 19190 Sollentuna, Sweden. · Pubmed 23603935
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 56 total) written by Lotus Mallbris about Psoriasis:

  • Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study. 2018
  • Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3. 2018
  • Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trials. 2018
  • Duration of Psoriatic Skin Disease as Risk Factor for Subsequent Onset of Psoriatic Arthritis. 2018
  • The effect of bodyweight on the efficacy and safety of ixekizumab: results from an integrated database of three randomised, controlled Phase 3 studies of patients with moderate-to-severe plaque psoriasis. 2017
  • Reaching complete or near-complete resolution of psoriasis: benefit and risk considerations. 2017
  • Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis. 2017
  • Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3). 2017
  • Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis. 2017
  • Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A). 2017
Show List of Full Article Records
Google Searches

Learn more about Lotus Mallbris using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Eli Lilly Corporation
Karolinska Institutions
Pfizer
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Eli Lilly Corporation
2018
  • Central Dermatology, St. Louis, Missouri. Electronic address: · Innovaderm Research Inc, Montreal, Quebec, Canada; Medical University of Graz, Graz, Austria. · Charité Universitätsmedizin Berlin, Berlin, Germany. · Eli Lilly and Company, Indianapolis, Indiana. · Buenos Aires Skin SA, Buenos Aires, Argentina. · Department of Dermatology, Westmead Hospital Dermatology Service, The University of Sydney, Westmead, Australia. · Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Pubmed 29803904
  • Herlev and Gentofte Hospital, Hellerup, Denmark. Electronic address: · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · University Hospitals Case Medical Center, Cleveland, Ohio. · Ameriderm Research, Ormond Beach, Florida; University of Central Florida, Orlando, Florida; University of Illinois, Urbana, Illinois. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 29548945
  • Dermatology Department, Toulouse University and Larrey Hospital, Toulouse, France. · Western University, London, ON, Canada. · Guenther Research Inc., London, ON, Canada. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Medicine (Dermatology), David Geffen School of Medicine, Los Angeles, CA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Division of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, USA. · Laval University and Centre de Recherche Dermatologique du Quebec Metropolitain, Quebec City, QC, Canada. · Pubmed 28881462
2017
  • Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Eli Lilly and Company, Indianapolis, IN, USA. · St. Louis University School of Medicine, St. Louis, MO, USA. · Pubmed 28370467
  • Oregon Medical Research Center, Suite G, 9495 S. Locust Street, Portland, OR 97223, OR, U.S.A. · Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K. · Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, NY, U.S.A. · Psoriasis Center at the Department of Dermatology, University Medical Centre Schleswig-Holstein, Campus Kiel, Germany. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. · Eli Lilly and Co., Indianapolis, IN, U.S.A. · Eli Lilly Belgium, Brussels, Belgium. · Dermatologikum Hamburg, Hamburg, Germany. · Pubmed 28301048
  • Oregon Medical Research Center, Portland, OR, USA. · Probity Medical Research and K. Papp Clinical Research, Waterloo, ON, Canada. · Department of Medicine (Dermatology), David Geffen School of Medicine, Los Angeles, CA, USA. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg, Hamburg, Germany. · Department of Dermatology, Miller School of Medicine, University of Miami, Miami, FL, USA. · Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan. · Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Department of Dermatology, Jichi Medical University, Shimotsuke, Tochigi, Japan. · Department of Medicine, Université Laval, Hôpital Hôtel-Dieu de Québec, Quebec, QC, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Quebec, QC, Canada. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 28190255
  • Oregon Medical Research Center, 9495 SW Locust St., Suite G, Portland, OR, 97223, USA. · K Papp Clinical Research and Probity Medical Research, Waterloo, Canada. · Dermatology Centre, Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical Dermatology Specialists, Inc., Atlanta, GA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28074446
  • Department of Dermatology, University of Utah, Salt Lake City, UT, USA. · Psoriasis Treatment Center of Central New Jersey, Windsor, NJ, USA. · Altman Dermatology Associates, Arlington Heights, IL, USA. · Lilly-NUS Centre for Clinical Pharmacology, Singapore City, Singapore. · Eli Lilly and Company, Indianapolis, IN, USA. · Eli Lilly and Company, Windlesham, UK. · Pubmed 27500949
  • Dermatologikum Hamburg and Georg-August-University, Göttingen, Germany. Electronic address: · Central Dermatology, St Louis, Missouri, USA. · K. Papp Clinical Research, Probity Medical Research, Waterloo, Ontario, Canada. · Department of Dermatology, New York Medical College, Valhalla, New York, USA. · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28780085
  • K. Papp Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Service de Dermatologie, AP-HP Hôpital Saint Louis, Sorbonne Paris Cité Université Paris Diderot, Paris, France. · Oregon Medical Research Center, Portland, OR, U.S.A. · Oregon Health and Science University, Portland, OR, U.S.A. · Departament of Dermatology, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil. · Department of Dermatology, Jichi Medical University, Shimotsuke, Japan. · Eli Lilly and Company, Indianapolis, IN, U.S.A. · Department of Dermatology, University of Connecticut Health Center, Farmington, CT, U.S.A. · Pubmed 28600810
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · The Danish Heart Foundation, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermatology, New York Medical College, Valhalla, New York, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK. · Department of Dermatology, Edouard Herriot Hospital, University Claude Bernard Lyon-1, University of Lyon, Lyon, France. · Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy. · Division of Rheumatology, Department of Medicine, University of Toronto, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28483767
  • Department of Dermatology, University of Connecticut Health Center and Probity Medical Research, Farmington, Connecticut. Electronic address: · Central Dermatology PC, St Louis, Missouri. · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Psoriasis-Center, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Jichi Medical University, Shimotsuke, Tochigi, Japan. · Innovaderm Research, Montreal, Canada. · Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Dermatology, Paul Sabatier University, Toulouse, France. · Icahn School of Medicine at Mount Sinai, New York, New York. · Eli Lilly and Company, Indianapolis, Indiana. · Dermatologikum Hamburg and SCIderm, Hamburg, Germany. · Pubmed 27889292
  • Department of Dermatology, New York Medical College, Valhalla, NY, USA. · Department of Dermatology, University Hospital of Nice, Nice, France. · Murdough Family Center for Psoriasis, University Hospitals Case Medical Center, Cleveland, OH, USA. · Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg, Germany. · Regional Medical Affairs, Lilly France, Neuilly-sur-Seine, France. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Dermatology, Psoriasis-Center, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 27696577
2016
  • From the Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago (K.B.G.) · Oregon Medical Research Center, Portland (A.B.) · K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), and the Department of Medicine, Division of Dermatology, Dalhousie University, Halifax, NS (R.G.L.) - both in Canada · the Department of Dermatology, University of Münster, Münster (T.L.), and SCIderm Research Institute and Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany · the Department of Dermatology, Jichi Medical University, Shimotsuke-shi, Japan (M.O.) · Lilly Research Laboratories, Eli Lilly, Indianapolis (D.A., S.G.B., D.K.B., G.S.C., J.E., R.J.K., T.M.M., B.J.N., O.O.O., R.J.S., F.Z., L.M.) · and the Department of Dermatology, Saint Louis University School of Medicine, St. Louis (C.L.L.). · Pubmed 27299809
Karolinska Institutions
2017
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. · Unit of Dermatology and Venerology, Karolinska Institutet, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Department of Dermatology, Department of Biostatistics and Epidemiology, and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania. · National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: · Pubmed 28826925
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Departments of Dermatology, Preventive Medicine, and Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Northwestern Medicine Multidisciplinary Eczema Center, Chicago, Illinois. · Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Pubmed 27742169
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Stockholm, Sweden. · The Danish Heart Foundation, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Psoriasis-Center at the Dept. of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Pubmed 27439545
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · Dermatology Centre, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · The Danish Heart Foundation, DK-1127, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, DK-1353, Copenhagen, Denmark. · Pubmed 28555725
2016
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; The Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Pubmed 27283226
  • Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · The Danish Heart Foundation, DK-1127, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, DK-1353, Copenhagen, Denmark. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 27038335
  • Department of Dermato-Allergology, University of Copenhagen, 2900, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, M6 8HD, U.K. · Sorbonne Paris Cité Université Paris Diderot, INSERM U1163, Imagine Institute, Necker Hospital, Paris, France. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark. · The Danish Heart Foundation, DK-1127, Copenhagen, Denmark. · The National Institute of Public Health, University of Southern Denmark, DK-1353, Copenhagen, Denmark. · Department of Dermato-Allergology, University of Copenhagen, 2900, Hellerup, Denmark. · Pubmed 26959083
  • Probity Medical Research and K. Papp Clinical Research Inc, Waterloo, Ontario, Canada. · Rockefeller University, New York, New York. · Wake Forest Baptist Health, Winston-Salem, North Carolina. · Dalhousie University, Halifax, Nova Scotia, Canada. · Comprehensive Center for Inflammation Research, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Dermatology, University of Texas Medical School, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 26899199
  • Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; The Danish Heart Foundation, Copenhagen, Denmark; The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Pubmed 26763428
  • Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900 Hellerup. · Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900 Hellerup. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 26715401
2015
  • Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Electronic address: · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. · Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Pubmed 26386630
  • Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark2The Danish Heart Foundation, Copenhagen, Denmark3National Institute of Public Health, University of Southern Denmark, Copenhagen. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. · Pubmed 26222707
  • Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, DK-2900, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermato-allergology, Gentofte Hospital, University of Copenhagen, Hellerup, DK-2900, Denmark. · Pubmed 25801416
  • Department of Cardiology, Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Unit of Dermatology and Venereology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermato-allergology, Gentofte Hospital, University of Copenhagen, DK-2900, Hellerup, Denmark. · Pubmed 25781210
2010
  • Unit of Dermatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19645825
2009
  • Dermatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19480679
2016
  • Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Pubmed 26716136
2015
  • Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Pubmed 25766866
2009
  • Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19734975
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. · Pubmed 19133922
2008
  • Department of Medicine, Molecular Unit of Dermatology and Venereology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden. · Pubmed 18200047
Pfizer
2017
  • The Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. · Dermatrials Research Inc, Hamilton, ON, Canada. · UCLA School of Medicine, Los Angeles, CA, USA. · Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Indiana School of Medicine, Indianapolis, IN, USA. · DermResearch PLLC, Louisville, KY, USA. · Pfizer Inc, Global Innovative Pharmaceuticals, Groton, CT, USA. · Pfizer Inc, Collegeville, PA, USA. · Pubmed 27600367
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Quality Measures and Research, Clalit Health Services, Tel Aviv, Israel; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. · University of Texas Health Science Center, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Collegeville, Pennsylvania. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark. · Pfizer Inc, New York, New York. · Pubmed 28711084
  • Division of Rheumatology, Department of Musculoskeletal Sciences, University Hospitals Leuven, Belgium. · Pfizer, Collegeville, PA, USA. · inVentiv Health, Princeton, NJ, USA. · Pubmed 27606545
2016
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Skin Center for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Clinica Dermacross, Santiago, Chile. · Pfizer Inc, Collegeville, Pennsylvania. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, New York, New York. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 27692733
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Toulouse University and Larrey Hospital, Toulouse, France. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Pubmed 27271195
2015
  • Dermatology Centre, Manchester Academic Health Science Centre, Salford Royal Hospital, University of Manchester, M6 8HD, Manchester, U.K. · University of Kiel, Kiel, Germany. · Specialty Care, Pfizer Inc, Collegeville, PA, U.S.A. · Pubmed 25913550
  • Innovaderm Research, Montreal, QC, Canada. · Aarhus University Hospital, Aarhus, Denmark. · Department of Medicine/Dermatology, UCLA School of Medicine, Los Angeles, CA, U.S.A. · Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, U.K. · Skin and Cancer Foundation Inc., The University of Melbourne, Carlton, Vic., Australia. · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Pfizer Inc, Groton, CT, U.S.A. · Pfizer Inc, New York, NY, U.S.A. · Pfizer Inc, Collegeville, PA, U.S.A. · Pubmed 25418186
  • Guy's and St Thomas' NHS Foundation Trust, London, UK. · Katholieke Universiteit Leuven, Leuven, Belgium. · Quintiles, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Europe, Rome, Italy. · Pubmed 25535650
  • Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Hospital General de Agudos, Buenos Aires, Argentina. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Specialty Care, Medical Affairs Europe, Inflammation, Rome, Italy. · Pfizer Italia S.r.l., Rome, Italy. · Formerly of Pfizer Inc, Collegeville, PA, USA. · Pubmed 25376448
2014
  • Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain. · St Vincent's University Hospital, Elm Park, Dublin, Ireland. · Lotus Mallbris, Pfizer Global Medical Dermatology Lead, Philadelphia, USA. · Department of Dermatology, Federal Academic Teaching Hospital, Feldkirch, Austria. · Pubmed 24752135
2014
  • Formerly of Pfizer Inc,, 3921 Glenlake Garden Drive, Raleigh, NC 27612, USA. · Pubmed 25091090
2013
  • Department of Health Economics, Pfizer AB, 19190 Sollentuna, Sweden. · Pubmed 23603935
4 Other Locations Show
Yearly article counts 041812122100241
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.